FIZN yields 1.87% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, FIZN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FIZN + JNJ for your $10,000?
First Citizens Bancshares, Inc., through its subsidiary, First Citizens National Bank, provides various commercial banking services to individuals and corporate customer to in the mid-southern United States. The company offers checking and savings deposits, as well as certificates of deposit; and residential, commercial, and consumer lending products. It also provides personal and home loans; and home equity line of credit. In addition, the company provides commercial real estate, construction and facility, equipment financing, residential development and construction, operating loans and lines of credit, and SBA and United States department of agriculture (USDA) loans, as well as debit and credit card services. Further, it offers home purchase and refinancing, and reverse mortgages; mobile, telephone/text, and online banking services; e-statements; investment, insurance, and retirement and benefit services; and trust, overdraft, identity theft protection, and treasury services, as well as safe deposit boxes. First Citizens Bancshares, Inc. was founded in 1889 and is headquartered in Dyersburg, Tennessee.
Full FIZN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.